The analysis of forecasted Non-Steroids Antiinflammatory and Antirheumatic medicine sales in Italy, expressed in US Dollars Per Capita, indicates a gradual decline from 2024 to 2028. In 2023, the value was stable, but starting in 2024, a decrease is expected each year. From 2024 to 2025, there is a predicted decrease of approximately 4.2%. The same decreasing pattern continues annually with percentage changes based on decreasing values. Overall, the compound annual growth rate (CAGR) over the five-year period shows an average decline, reflecting market saturation or reduced consumption.
Future trends to watch include potential impacts of generic drug penetration, shifts in healthcare policy, and advancements in alternative treatment options, which may further influence the market demand and sales dynamics.
